FDA plans black box warning for US COVID vaccines
Digest more
NEXSPIKE is Moderna’s third product to receive a positive CHMP opinion alongside Spikevax (COVID-19 Vaccine, mRNA) and ...
Moderna on Monday said that the European Medicines Agency's Committee for Medicinal Products for Human Use recommended the marketing authorization of mNexspike, a new Covid-19 vaccine. The committee's ...
Moderna on Monday said its combination COVID-19 and flu shot elicits a stronger immune response against both viruses than licensed vaccines on the market, promising findings for the mRNA company ...
The decision applies to adolescents and adults and aligns with earlier US authorization for higher-risk groups.
MedPage Today on MSN
RFK Jr.’s Former Group Urges FDA to Revoke COVID Vax Licenses
An anti-vaccine organization founded by HHS Secretary Robert F. Kennedy Jr. is urging the FDA he now oversees to pull the licenses of Pfizer's and Moderna's COVID-19 vaccines.
Not all children are eligible for the new Moderna COVID shots. Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, ...
Moderna Inc. (NASDAQ:MRNA) is one of the high short interest stocks to buy right now. On November 20, Moderna announced that ...
Revenue -- $1.9 billion reported for the quarter, compared to prior sales cycles impacted by earlier U.S. COVID-19 vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback